Table 1 Clinicopathologic characteristics of EOC patients
From: Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer
Variable | Total number % | |
|---|---|---|
Age median (range) | 52 (22–73) | |
< 50 | 43 | 41 |
≥ 50 | 61 | 59 |
FIGO stage | ||
I | 20 | 19 |
II | 16 | 16 |
III | 50 | 48 |
IV | 18 | 17 |
Histological grade | ||
G1 | 10 | 10 |
G2 | 14 | 13 |
G3 | 80 | 77 |
Lymph nodal involvement | ||
Positive | 40 | 38 |
Negative | 64 | 62 |
Residual tumor size | ||
0 mm | 76 | 75 |
0–10 mm | 28 | 25 |
CA125 serum level median (range) | 263 (19–8410) | |
≤ 35 U/ml | 7 | 7 |
> 35 U/ml | 97 | 93 |
ER expression | ||
Positive | 58 | 56 |
Negative | 46 | 44 |
PR expression | ||
Positive | 47 | 45 |
Negative | 57 | 55 |
Her1 expression | ||
Positive | 37 | 36 |
Negative | 67 | 64 |
Her2 expression | ||
Positive | 51 | 49 |
Negative | 53 | 51 |
P53 expression | ||
Positive | 73 | 70 |
Negative | 31 | 30 |